Diphenadione

From WikiMD's WELLNESSPEDIA

Diphenadione is a vitamin K antagonist and an anticoagulant, which is often used as a rodenticide. It is a second-generation derivative in the family of coumarin-based anticoagulants. Diphenadione was first registered in the United States in 1953.

Mechanism of Action[edit]

Diphenadione exerts its anticoagulant properties by inhibiting the vitamin K epoxide reductase enzyme. This enzyme is responsible for the recycling of vitamin K in the body. By inhibiting this enzyme, Diphenadione disrupts the blood clotting process, leading to uncontrolled bleeding and eventual death in rodents.

Uses[edit]

Diphenadione is primarily used as a rodenticide. It is effective against a variety of rodents including rats, mice, and squirrels. It is often used in situations where first-generation anticoagulants have failed due to resistance.

Toxicity[edit]

Diphenadione is highly toxic to mammals and birds, and slightly toxic to fish and aquatic invertebrates. It is classified as a Category C, possible human carcinogen. Exposure to Diphenadione can lead to a variety of symptoms including nausea, vomiting, abdominal pain, and bleeding.

Treatment[edit]

Treatment for Diphenadione poisoning involves discontinuing exposure to the substance and administering vitamin K1 therapy. In severe cases, blood transfusion may be necessary.

See Also[edit]

References[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.